MUMBAI: Lupin has signed an agreement to acquire five legacy brands in gastroenterology, urology and anti-infectives from Menarini, along with the associated trademark rights. According to a BSE filing, the deal is around Rs 100 crore. Further details on the size of the deal were not disclosed.The brands are Piclin, Menoctyl, Sucramal O, Pyridium and Distaclor, a statement said. Their turnover for FY23 stood at about Rs 32 crore.Lupin has been exclusively marketing these brands in the domestic market since July 2021 under a distribution and promotion agreement...
MUMBAI: Lupin has signed an agreement to acquire five legacy brands in gastroenterology, urology and anti-infectives from Menarini, along with the associated trademark...
Asian stocks made gains on Wednesday as there are reports indicating that China’s major banks are preparing to decrease interest rates. Additionally, investors...
Sensex, Nifty, Share Prices LIVE: Indian markets anticipate dull opening amid global uncertainity; RBI meeting and inflation data awaited for direction
Source...